P04.41
Newborn affected by maternal use of cocaine
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code P04.41 refers to newborns who are affected by maternal use of cocaine during pregnancy. Cocaine is a powerful stimulant drug, and its use during pregnancy can have significant effects on the developing fetus. Babies born to mothers who used cocaine may experience a range of health issues, both immediately after birth and long term. Recognizing the implications of maternal cocaine use is crucial for healthcare providers and parents to ensure proper care and intervention.
Causes & Symptoms
Clinical Causes: Maternal consumption of cocaine during pregnancy Use of illicit cocaine, which crosses the placental barrier to reach the fetus Lack of prenatal care or substance abuse treatment during pregnancy
Key Symptoms: Low birth weight and prematurity Problems with feeding and poor weight gain Irritability and agitation High pitched crying Tremors or seizures Respiratory problems such as rapid breathing or nasal congestion Poor muscle tone or hyperactivity Signs of withdrawal, like yawning or sweating Sleep disturbances
Diagnostic & Treatment
Diagnosis Path: Diagnosis of a newborn affected by maternal cocaine use is based on a combination of maternal history, observed symptoms in the newborn, and laboratory tests. These tests may include:
Treatment Protocols: Management of infants affected by prenatal cocaine exposure focuses on supportive care to address immediate health concerns. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is P04.41 a billable ICD-10 code?
Yes, P04.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P04.41?
Clinical documentation must specify the nature of Newborn affected by maternal use of cocaine and any associated comorbidities for accurate reporting.
Cite this Clinical Reference